Chang Jia-Feng, Yeh Jih-Chen, Chiu Ya-Lin, Liou Jian-Chiun, Hsiung Jing-Ru, Tung Tao-Hsin
Department of Internal Medicine, En Chu Kong Hospital, New Taipei City, Taiwan; Ph.D. Program in Nutrition and Food Science, College of Human Ecology; Graduate Institution of Biomedical and Pharmaceutical Science, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Department of Dentistry, Far Eastern Memorial Hospital, Taipei, Taiwan; School of Dentistry, Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei.
Am J Med. 2017 Jan;130(1):61-69.e1. doi: 10.1016/j.amjmed.2016.08.024. Epub 2016 Sep 9.
No large epidemiological study has been conducted to investigate the interaction and joint effects of periodontal pocket depth and hyperglycemia on progression of chronic kidney disease in patients with periodontal diseases.
Periodontal pocket depth was utilized for the grading severity of periodontal disease in 2831 patients from January 2002 to June 2013. Progression of chronic kidney disease was defined as progression of color intensity in glomerular filtration rate and albuminuria grid of updated Kidney Disease-Improving Global Outcomes guidelines. Multivariable-adjusted hazard ratios (aHR) in various models were presented across different levels of periodontal pocket depth and hemoglobin A1c (HbA1c) in forest plots and 3-dimensional histograms.
During 7621 person-years of follow-up, periodontal pocket depth and HbA1C levels were robustly associated with incremental risks for progression of chronic kidney disease (aHR 3.1; 95% confidence interval [CI], 2.0-4.6 for periodontal pocket depth >4.5 mm, and 2.5; 95% CI, 1.1-5.4 for HbA1C >6.5%, respectively). The interaction between periodontal pocket depth and HbA1C on progression of chronic kidney disease was strong (P <.01). Patients with higher periodontal pocket depth (>4.5 mm) and higher HbA1C (>6.5%) had the greatest risk (aHR 4.2; 95% CI, 1.7-6.8) compared with the lowest aHR group (periodontal pocket depth ≤3.8 mm and HbA1C ≤6%).
Our study identified combined periodontal pocket depth and HbA1C as a valuable predictor of progression of chronic kidney disease in patients with periodontal diseases. While considering the interaction between periodontal diseases and hyperglycemia, periodontal survey and optimizing glycemic control are warranted to minimize the risk of worsening renal function.
尚未开展大型流行病学研究来调查牙周袋深度与高血糖对牙周疾病患者慢性肾脏病进展的相互作用及联合效应。
2002年1月至2013年6月期间,对2831例患者的牙周袋深度用于牙周疾病严重程度分级。慢性肾脏病进展定义为符合更新后的改善全球肾脏病预后组织(KDIGO)指南中肾小球滤过率及蛋白尿分级的颜色强度进展。森林图和三维直方图展示了不同模型中不同牙周袋深度和糖化血红蛋白(HbA1c)水平下的多变量调整风险比(aHR)。
在7621人年的随访期间,牙周袋深度和HbA1c水平与慢性肾脏病进展风险增加密切相关(牙周袋深度>4.5mm时,aHR为3.1;95%置信区间[CI]为2.0 - 4.6;HbA1c>6.5%时,aHR为2.5;95%CI为1.1 - 5.4)。牙周袋深度与HbA1c对慢性肾脏病进展的相互作用很强(P<0.01)。与最低aHR组(牙周袋深度≤3.8mm且HbA1c≤6%)相比,牙周袋深度较高(>4.5mm)且HbA1c较高(>6.5%)的患者风险最大(aHR为4.2;95%CI为1.7 - 6.8)。
我们的研究确定牙周袋深度与HbA1c联合是牙周疾病患者慢性肾脏病进展的重要预测指标。考虑到牙周疾病与高血糖之间的相互作用,有必要进行牙周检查并优化血糖控制,以降低肾功能恶化风险。